Works matching IS 10834389 AND DT 2022 AND VI 27 AND IP 2
Results: 13
Effects of enhanced education for patients with the Helicobacter pylori infection: A systematic review and meta‐analysis.
- Published in:
- Helicobacter, 2022, v. 27, n. 2, p. 1, doi. 10.1111/hel.12880
- By:
- Publication type:
- Article
Exploration of the molecular mechanisms underlying the antibiotic resistance of Helicobacter pylori: A whole‐genome sequencing‐based study in Southern China.
- Published in:
- Helicobacter, 2022, v. 27, n. 2, p. 1, doi. 10.1111/hel.12879
- By:
- Publication type:
- Article
Influence of Helicobacter pylori infection on PD‐1/PD‐L1 blockade therapy needs more attention.
- Published in:
- Helicobacter, 2022, v. 27, n. 2, p. 1, doi. 10.1111/hel.12878
- By:
- Publication type:
- Article
Extracellular vesicles from helicobacter pylori‐infected cells and helicobacter pylori outer membrane vesicles in atherosclerosis.
- Published in:
- Helicobacter, 2022, v. 27, n. 2, p. 1, doi. 10.1111/hel.12877
- By:
- Publication type:
- Article
Rabeprazole plus amoxicillin dual therapy is equally effective to bismuth‐containing quadruple therapy for Helicobacter pylori eradication in central China: A single‐center, prospective, open‐label, randomized‐controlled trial.
- Published in:
- Helicobacter, 2022, v. 27, n. 2, p. 1, doi. 10.1111/hel.12876
- By:
- Publication type:
- Article
GM‐CSF is key in the efficacy of vaccine‐induced reduction of Helicobacter pylori infection.
- Published in:
- Helicobacter, 2022, v. 27, n. 2, p. 1, doi. 10.1111/hel.12875
- By:
- Publication type:
- Article
Need for standardization and harmonization of Helicobacter pylori antimicrobial susceptibility testing.
- Published in:
- Helicobacter, 2022, v. 27, n. 2, p. 1, doi. 10.1111/hel.12873
- By:
- Publication type:
- Article
Pepsinogen II in gastritis and Helicobacter pylori infection.
- Published in:
- Helicobacter, 2022, v. 27, n. 2, p. 1, doi. 10.1111/hel.12872
- By:
- Publication type:
- Article
Dynamic changes in antibiotic resistance genes and gut microbiota after Helicobacter pylori eradication therapies.
- Published in:
- Helicobacter, 2022, v. 27, n. 2, p. 1, doi. 10.1111/hel.12871
- By:
- Publication type:
- Article
Saccharomyces boulardii CNCM I‐745 supplementation modifies the fecal resistome during Helicobacter pylori eradication therapy.
- Published in:
- Helicobacter, 2022, v. 27, n. 2, p. 1, doi. 10.1111/hel.12870
- By:
- Publication type:
- Article
Effect of enhanced patient instructions on Helicobacter pylori eradication: A systematic review and meta‐analysis of randomized controlled trials.
- Published in:
- Helicobacter, 2022, v. 27, n. 2, p. 1, doi. 10.1111/hel.12869
- By:
- Publication type:
- Article
Campylobacter concisus gastritis masquerading as Helicobacter pylori on gastric biopsy.
- Published in:
- Helicobacter, 2022, v. 27, n. 2, p. 1, doi. 10.1111/hel.12864
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Helicobacter, 2022, v. 27, n. 2, p. 1, doi. 10.1111/hel.12819
- Publication type:
- Article